Inhibikase Therapeutics Inc (IKT)
R&D to Revenue
0.00%
Quarterly · Period ending:
IKT R&D to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
IKT Quarterly R&D/Revenue (103.85% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
IKT r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 300,298,000% | |
| 4,053.7785% | |
| 3,896.313% | |
| 4,423.619% | |
| 4,804.7038% | |
| 40,894.9801% | |
| 45,515.6136% | |
| 6,554.2591% | |
| 174,395.9877% | |
| 960.41% | |
| 174.7886% | |
| 172.8198% | |
| 133.1706% | |
| 319.9814% | |
| 119.8511% | |
| 104.5523% | |
| 111.503% | |
| 204.9071% | |
| 283.9778% | |
| 263.2001% | |
| 108.6277% | |
| 84.6779% | |
| 75.2598% | |
| 103.8451% |